Showing results (861-870 of 967) with videos related to
Sort By:
Pageof 97
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 29, 2026
Effect of Butyrate-Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and TremelimumabKazuhiro Nouso, Akiko Wakuta, Shohei Shiota, et al.European Heart Journal. Acute Cardiovascular Care|January 25, 2020
Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudyHideki Wada, Manabu Ogita, Satoru Suwa, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic SteatohepatitisJan Best, Lars P Bechmann, Jan-Peter Sowa, et al.International Heart Journal|September 14, 2020
Prognostic Impact of B-Type Natriuretic Peptide on Long-Term Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction Without Creatine Kinase ElevationNorihito Takahashi, Manabu Ogita, Satoru Suwa, et al.International Heart Journal|May 17, 2021
Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial InfarctionHideki Wada, Manabu Ogita, Satoru Suwa, et al.Journal of Cardiology|July 8, 2017
Off-hours presentation does not affect in-hospital mortality of Japanese patients with acute myocardial infarction: J-MINUET substudyManabu Ogita, Satoru Suwa, Hideki Ebina, et al.Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2024
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapyToshifumi Tada, Masayuki Kurosaki, Hidenori Toyoda, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.Cancer Reports (Hoboken, N.J.)|June 11, 2021
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experienceAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.Pageof 97